ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2025.12926 ETM-30-3-12926 Retraction [Retracted] miR-372 promotes breast cancer cell proliferation by directly targeting LATS2 ChengXueyuan ChenJunqiang HuangZhong 092025 21072025 30 3 176 Copyright: © 2025 Cheng et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Exp Ther Med 15:2812–2817, 2018; DOI: 10.3892/etm.2018.5761

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the flow cytometric data shown in Fig. 3C on p. 2815 were strikingly similar to data that had already appeared in different form in another article written by different authors at different research institutes, which had already been published in the journal OncoTarget. After having performed an independent analysis of the data in the Editorial Office, it came to light that certain of the colony-formation assay data (the ‘Control’ data) in Fig. 2C on p. 2814 were also included in an article submitted for publication to another journal at around the same time.

In view of the fact that the abovementioned data had already apparently been published previously, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.